Browsing by Author "Bridges, S. Louis"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss
    (American Physiological Society, 2019-10-07) Xu, Guanlan; Thielen, Lance A.; Chen, Junqin; Grayson, Truman B.; Grimes, Tiffany; Bridges, S. Louis; Tse, Hubert M.; Smith, Blair; Patel, Rakesh; Li, Peng; Evans-Molina, Carmella; Ovalle, Fernando; Shalev, Anath; Pediatrics, School of Medicine
    Pancreatic beta-cell death is a major factor in the pathogenesis of type 1 diabetes (T1D), but straightforward methods to measure beta-cell loss in humans are lacking, underlining the need for novel biomarkers. Using studies in INS-1 cells, human islets, diabetic mice, and serum samples of subjects with T1D at different stages, we have identified serum miR-204 as an early biomarker of T1D-associated beta-cell loss in humans. MiR-204 is a highly enriched microRNA in human beta-cells, and we found that it is released from dying beta-cells and detectable in human serum. We further discovered that serum miR-204 was elevated in children and adults with T1D and in autoantibody-positive at-risk subjects but not in type 2 diabetes or other autoimmune diseases and was inversely correlated with remaining beta-cell function in recent-onset T1D. Thus, serum miR-204 may provide a much needed novel approach to assess early T1D-associated human beta-cell loss even before onset of overt disease.